205 related articles for article (PubMed ID: 34692494)
1. Blood-Brain Barrier Repair of Bevacizumab and Corticosteroid as Prediction of Clinical Improvement and Relapse Risk in Radiation-Induced Brain Necrosis: A Retrospective Observational Study.
Xue R; Chen M; Cai J; Deng Z; Pan D; Liu X; Li Y; Rong X; Li H; Xu Y; Shen Q; Tang Y
Front Oncol; 2021; 11():720417. PubMed ID: 34692494
[TBL] [Abstract][Full Text] [Related]
2. Clinical Variables for Prediction of the Therapeutic Effects of Bevacizumab Monotherapy in Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
Li Y; Huang X; Jiang J; Hu W; Hu J; Cai J; Rong X; Cheng J; Xu Y; Wu R; Luo J; Tang Y
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):621-629. PubMed ID: 29413276
[TBL] [Abstract][Full Text] [Related]
3. In Vivo DCE-MRI for the Discrimination Between Glioblastoma and Radiation Necrosis in Rats.
Bolcaen J; Descamps B; Acou M; Deblaere K; den Broecke CV; Boterberg T; Vanhove C; Goethals I
Mol Imaging Biol; 2017 Dec; 19(6):857-866. PubMed ID: 28303489
[TBL] [Abstract][Full Text] [Related]
4. Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A Randomized Controlled Trial.
Xu Y; Rong X; Hu W; Huang X; Li Y; Zheng D; Cai Z; Zuo Z; Tang Y
Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1087-1095. PubMed ID: 29885994
[TBL] [Abstract][Full Text] [Related]
5. Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.
Dashti SR; Spalding A; Kadner RJ; Yao T; Kumar A; Sun DA; LaRocca R
J Neurosurg Pediatr; 2015 Jan; 15(1):20-5. PubMed ID: 25360851
[TBL] [Abstract][Full Text] [Related]
6. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis.
Khan M; Zhao Z; Arooj S; Liao G
BMC Cancer; 2021 Feb; 21(1):167. PubMed ID: 33593308
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts.
Li J; He J; Cai L; Lai M; Hu Q; Ren C; Wen L; Wang J; Zhou J; Zhou Z; Li S; Ye M; Shan C; Chen L; Zhou C
Ann Palliat Med; 2021 Feb; 10(2):2018-2026. PubMed ID: 33549015
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab Combined with Corticosteroids Does Not Improve the Clinical Outcome of Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
Li H; Rong X; Hu W; Yang Y; Lei M; Wen W; Yue Z; Huang X; Chua MLK; Li Y; Cai J; He L; Pan D; Cheng J; Pi Y; Xue R; Xu Y; Tang Y
Front Oncol; 2021; 11():746941. PubMed ID: 34650930
[TBL] [Abstract][Full Text] [Related]
10. Blood-Brain Barrier Disruption in Mild Traumatic Brain Injury Patients with Post-Concussion Syndrome: Evaluation with Region-Based Quantification of Dynamic Contrast-Enhanced MR Imaging Parameters Using Automatic Whole-Brain Segmentation.
Yoen H; Yoo RE; Choi SH; Kim E; Oh BM; Yang D; Hwang I; Kang KM; Yun TJ; Kim JH; Sohn CH
Korean J Radiol; 2021 Jan; 22(1):118-130. PubMed ID: 32783413
[TBL] [Abstract][Full Text] [Related]
11. Higher Blood-brain barrier permeability in patients with major depressive disorder identified by DCE-MRI imaging.
Shang B; Wang T; Zhao S; Yi S; Zhang T; Yang Y; Zhang F; Zhang D; Xu X; Xu J; Shan B; Cheng Y
Psychiatry Res Neuroimaging; 2024 Jan; 337():111761. PubMed ID: 38061159
[TBL] [Abstract][Full Text] [Related]
12. Divergent white matter changes in patients with nasopharyngeal carcinoma post-radiotherapy with different outcomes: a potential biomarker for prediction of radiation necrosis.
Lin X; Li Z; Chen S; Yang Y; He H; Lv X; Qiu Y
Eur Radiol; 2022 Oct; 32(10):7036-7047. PubMed ID: 35687134
[TBL] [Abstract][Full Text] [Related]
13. Single low-dose targeted bevacizumab infusion in adult patients with steroid-refractory radiation necrosis of the brain: a phase II open-label prospective clinical trial.
Dashti SR; Kadner RJ; Folley BS; Sheehan JP; Han DY; Kryscio RJ; Carter MB; Shields LBE; Plato BM; La Rocca RV; Spalding AC; Yao TL; Fraser JF
J Neurosurg; 2022 Dec; 137(6):1676-1686. PubMed ID: 35426830
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors.
Moore A; Yust-Katz S; Icht O; Eliyahou R; Gordon N; Cohen AY; Goldstein IM; Peled N; Seigal T; Amiel A; Dudnik E
J Neurol Sci; 2021 Aug; 427():117556. PubMed ID: 34186494
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast enhanced MRI for characterization of blood-brain-barrier dysfunction after traumatic brain injury.
Ware JB; Sinha S; Morrison J; Walter AE; Gugger JJ; Schneider ALC; Dabrowski C; Zamore H; Wesley L; Magdamo B; Petrov D; Kim JJ; Diaz-Arrastia R; Sandsmark DK
Neuroimage Clin; 2022; 36():103236. PubMed ID: 36274377
[TBL] [Abstract][Full Text] [Related]
16. Quantitative dynamic contrast-enhanced MR imaging shows widespread blood-brain barrier disruption in mild traumatic brain injury patients with post-concussion syndrome.
Yoo RE; Choi SH; Oh BM; Do Shin S; Lee EJ; Shin DJ; Jo SW; Kang KM; Yun TJ; Kim JH; Sohn CH
Eur Radiol; 2019 Mar; 29(3):1308-1317. PubMed ID: 30066251
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of blood brain barrier permeability and tissue microstructure following controlled cortical impact injury in rat: A dynamic contrast-enhanced magnetic resonance imaging and diffusion kurtosis imaging study.
Yu M; Wang M; Yang D; Wei X; Li W
Magn Reson Imaging; 2019 Oct; 62():1-9. PubMed ID: 30660704
[TBL] [Abstract][Full Text] [Related]
18. Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery.
Boothe D; Young R; Yamada Y; Prager A; Chan T; Beal K
Neuro Oncol; 2013 Sep; 15(9):1257-63. PubMed ID: 23814264
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of dynamic contrast-enhanced MRI derived microvascular permeability in recurrent glioblastoma treated with bevacizumab.
Kickingereder P; Wiestler B; Graf M; Heiland S; Schlemmer HP; Wick W; Wick A; Bendszus M; Radbruch A
J Neurooncol; 2015 Jan; 121(2):373-80. PubMed ID: 25359396
[TBL] [Abstract][Full Text] [Related]
20. Imaging correlates of the blood-brain barrier disruption in HIV-associated neurocognitive disorder and therapeutic implications.
Chaganti J; Marripudi K; Staub LP; Rae CD; Gates TM; Moffat KJ; Brew BJ
AIDS; 2019 Oct; 33(12):1843-1852. PubMed ID: 31274535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
